Advertisement
Home Tags Blood Disorders

Tag: Blood Disorders

Following a blood shortage triggered by the Fourth of July holiday week

Red Cross Issues Nationwide Call for Blood Donations

0
While all blood types are needed, type O negative and positive are especially crucial
Individual blood donations will no longer need to be tested for the Zika virus

FDA Drops Zika Testing for Blood Donors

0
Agency recommends moving away from testing each individual donation to testing pooled donations
Palynziq (pegvaliase-pqpz) has been approved by the U.S. Food and Drug Administration to treat phenylketonuria

FDA Approves Palynziq for Phenylketonuria

0
Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations
Each hour of delay in detecting abnormal lactates in patients with sepsis increases the odds of in-hospital death

Delay of Lactate Draws in Sepsis Ups Risk of In-Hospital Death

0
Systematic early lactate measurements speed antibiotic administration, improve outcomes
Screening blood donations for Zika virus in the United States is costly with low yield

Screening Blood Donations for Zika Virus Is Costly, Low Yield

0
Nine donations were confirmed positive; six of these had travelled to ZIKV-active areas
For patients with severe β-thalassemia

Gene Therapy Found to Be Promising for β-Thalassemia

0
CD34+ cells transduced with BB305 vector lowered or eliminated need for red-cell transfusions
From 2011 to 2014

RBC, Plasma Transfusions Drop From 2011 to 2014

0
Red blood cell and plasma transfusions decreased, while platelet transfusions remained stable
Low serum sodium is associated with cognitive impairment and cognitive decline among community-dwelling older men

Low Serum Sodium Linked to Cognitive Decline in Older Men

0
126 to 140 mmol/L linked to increased odds of prevalent cognitive impairment, decline in older men
For patients with severe hereditary hemorrhagic telangiectasia-related bleeding

IV Bevacizumab Effective for Severe HHT-Related Bleeding

0
Drop in RBC transfusion requirements, epistaxis severity in hereditary hemorrhagic telangiectasia
Patients with myeloproliferative neoplasms (MPNs) have increased risk of arterial thrombosis and venous thrombosis across all age groups and MPN subtypes

Increased Risk of Thrombosis in Myeloproliferative Neoplasms

0
Higher rates of thrombosis compared to matched controls; risk highest at and soon after diagnosis